Physician profile
Sonal Patel
NPI 1649235946
$1,990.31
in general payments reported to CMS, 2019-2025
19 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $15.37 · 2021: $128 · 2022: $266 · 2023: $508 · 2024: $436 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,375.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $351.78 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Mannkind Corporation | $329.86 | 2022-2024 | Afrezza |
| Glaxosmithkline, LLC. | $281.84 | 2019-2025 | Trelegy Ellipta |
| Novo Nordisk INC | $190.58 | 2021-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $187.27 | 2019 | |
| Exact Sciences Corporation | $120.17 | 2024 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $115.18 | 2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $80.73 | 2022-2023 | |
| Abbott Laboratories | $65.41 | 2025 | Freestyle Libre 3 |
| Recordati_rare_diseases_inc. | $49.30 | 2021-2025 | Isturisa |
| Sanofi-Aventis U.S. LLC | $34.87 | 2023 | |
| Pfizer INC. | $30.08 | 2022-2023 | |
| Abbvie INC. | $28.99 | 2022-2023 | |
| Ultragenyx Pharmaceutical INC. | $28.19 | 2021 | |
| Lilly USA, LLC | $26.72 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amryt Pharma Holdings LTD | $21.65 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $16.89 | 2023 | Abilify Maintena |
| Cranial Technologies, INC | $15.42 | 2021 | |
| Vivus LLC | $15.38 | 2023 | Qsymia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.